Developing an effective vaccine for Tuberculosis

As the largest dedicated TB vaccine research group on the African continent, SATVI (South African TB Vaccine Initiative) conducts clinical TB vaccine research with the ultimate goal of developing a new, effective and affordable TB vaccine, which has the potential to save hundreds of thousands of lives globally.